11![SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici](https://www.pdfsearch.io/img/54f2ad3f64be5039ac514789feb54821.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
12![SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici](https://www.pdfsearch.io/img/c40ca219fa2f6a35d50e45b32844bc11.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
13![Pharmacology / Medicine / Natalizumab / Alemtuzumab / Fingolimod / Clinical trial / Immunosuppressants / Immunology / Multiple sclerosis Pharmacology / Medicine / Natalizumab / Alemtuzumab / Fingolimod / Clinical trial / Immunosuppressants / Immunology / Multiple sclerosis](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|
14![Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1 Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1](https://www.pdfsearch.io/img/0b204345b3d78dddeefc8fee3aaf65d4.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|
15![Microsoft Word - Sanofi- 5.1 alemtuzumabPSD final.docx Microsoft Word - Sanofi- 5.1 alemtuzumabPSD final.docx](https://www.pdfsearch.io/img/4cb39b7baa39105aac5c52d724e69293.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-04-22 23:39:46
|
---|
16![Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and](https://www.pdfsearch.io/img/ae53c80da548361bf470505977c535cc.jpg) | Add to Reading ListSource URL: protectbenefitrisk.euLanguage: English - Date: 2014-07-16 01:09:14
|
---|
17![Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI WP5 Report 1:b:iv Benefit-Risk Wave 1 case study report: NATALIZUMAB Risk benefit case study with a focus on testing methodology. Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI WP5 Report 1:b:iv Benefit-Risk Wave 1 case study report: NATALIZUMAB Risk benefit case study with a focus on testing methodology.](https://www.pdfsearch.io/img/58e69404bf0a357077fa3068e3b084c3.jpg) | Add to Reading ListSource URL: protectbenefitrisk.euLanguage: English - Date: 2014-07-16 01:09:12
|
---|
18![Submission on Authority Required Medicines for the Post-market Review of Authority Required PBS Listings ® Gilenya (fingolimod) October 2014 Submission on Authority Required Medicines for the Post-market Review of Authority Required PBS Listings ® Gilenya (fingolimod) October 2014](https://www.pdfsearch.io/img/9c6c7090ac3458ebc7d5a539ea86f463.jpg) | Add to Reading ListSource URL: pbs.gov.auLanguage: English - Date: 2015-03-02 18:33:43
|
---|
19![Scottish Medicines Consortium Minutes of the SMC Meeting held on Tuesday 05 August 2014 The Lighthouse, 11 Mitchell Lane, Glasgow G1 3NU Present: Scottish Medicines Consortium Minutes of the SMC Meeting held on Tuesday 05 August 2014 The Lighthouse, 11 Mitchell Lane, Glasgow G1 3NU Present:](https://www.pdfsearch.io/img/9c5267daeed55a5bc7f672ab977d6df0.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
20![Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national](https://www.pdfsearch.io/img/8ac4ce3bcbfc1fe03eec8e7bb6be1f31.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-13 00:20:02
|
---|